“Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 1, 2010
April 22, 2024
47e1cf90-16d8-4331-8148-46e9e88b7770
Related Documents
Clinical Considerations for Therapeutic Cancer Vaccines: Guidance for Industry
Guidance DocumentOctober 1, 2011Center for Biologics Evaluation and Research
Cellular Therapy for Cardiac Disease: Guidance for Industry
Guidance DocumentOctober 1, 2010Center for Biologics Evaluation and Research
Requalification Method for Reentry of Blood Donors Deferred Because of Reactive Test Results for Antibody to Hepatitis B Core Antigen (Anti-HBc): Guidance for Industry
Guidance DocumentMay 1, 2010Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.